{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:44:45Z","timestamp":1782452685886,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National key R&D projects","award":["2022YFC2504800"],"award-info":[{"award-number":["2022YFC2504800"]}]},{"name":"Guangxi Traditional Chinese Medicine Technology Development and Promotion Project","award":["No.GZSY23-57"],"award-info":[{"award-number":["No.GZSY23-57"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-024-03640-7","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T05:21:51Z","timestamp":1731648111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular characteristics and antibiotic resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa in Nanning, China"],"prefix":"10.1186","volume":"24","author":[{"given":"Xianzhen","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiju","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"3640_CR1","doi-asserted-by":"crossref","unstructured":"Horcajada JP, Montero M, Oliver A, Sorl\u00ed L, Luque S, G\u00f3mez-Zorrilla S, Benito N, Grau S. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev 2019, 32(4).","DOI":"10.1128\/CMR.00031-19"},{"issue":"5","key":"3640_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/jac\/dkz030","volume":"74","author":"A P\u00e9rez","year":"2019","unstructured":"P\u00e9rez A, Gato E, P\u00e9rez-Llarena J, Fern\u00e1ndez-Cuenca F, Gude MJ, Ovia\u00f1o M, Pach\u00f3n ME, Garnacho J, Gonz\u00e1lez V, Pascual \u00c1, et al. High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2019;74(5):1244\u201352.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"3640_CR3","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/ofid\/ofy343","volume":"6","author":"D Shortridge","year":"2019","unstructured":"Shortridge D, Gales AC, Streit JM, Huband MD, Tsakris A, Jones RN. Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY antimicrobial surveillance program, 1997\u20132016. Open Forum Infect Dis. 2019;6(Suppl 1):S63\u20138.","journal-title":"Open Forum Infect Dis"},{"key":"3640_CR4","doi-asserted-by":"crossref","unstructured":"Montero MM, L\u00f3pez Montesinos I, Knobel H, Molas E, Sorl\u00ed L, Siverio-Par\u00e9s A, Prim N, Segura C, Duran-Jord\u00e0 X, Grau S et al. Risk factors for mortality among patients with Pseudomonas aeruginosa bloodstream infections: what is the influence of XDR phenotype on outcomes? J Clin Med 2020, 9(2).","DOI":"10.3390\/jcm9020514"},{"key":"3640_CR5","doi-asserted-by":"crossref","unstructured":"Buehrle DJ, Shields RK, Clarke LG, Potoski BA, Clancy CJ, Nguyen MH. Carbapenem-resistant Pseudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure. Antimicrob Agents Chemother 2017, 61(1).","DOI":"10.1128\/AAC.01243-16"},{"issue":"6","key":"3640_CR6","doi-asserted-by":"publisher","first-page":"106196","DOI":"10.1016\/j.ijantimicag.2020.106196","volume":"56","author":"E Del Barrio-Tofi\u00f1o","year":"2020","unstructured":"Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Oliver A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update. Int J Antimicrob Agents. 2020;56(6):106196.","journal-title":"Int J Antimicrob Agents"},{"key":"3640_CR7","doi-asserted-by":"crossref","unstructured":"Kocsis B, Gulyas D, Szabo D. Diversity and distribution of resistance markers in Pseudomonas aeruginosa international high-risk clones. Microorganisms 2021, 9(2).","DOI":"10.3390\/microorganisms9020359"},{"issue":"1","key":"3640_CR8","doi-asserted-by":"publisher","first-page":"106026","DOI":"10.1016\/j.ijantimicag.2020.106026","volume":"56","author":"M P\u00c9rez-V\u00c1zquez","year":"2020","unstructured":"P\u00c9rez-V\u00c1zquez M, Sola-Campoy PJ, Zurita \u00c1M, \u00c1vila A, G\u00d3mez-Bertomeu F, Sol\u00cds S, L\u00d3pez-Urrutia L, G\u00d3nzalez-Barber\u00c1 EM, Cercenado E, Bautista V, et al. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla(VIM-2), bla(VIM-1), bla(IMP-8), bla(VIM-20) and bla(KPC-2). Int J Antimicrob Agents. 2020;56(1):106026.","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"3640_CR9","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1128\/JCM.42.12.5644-5649.2004","volume":"42","author":"B Curran","year":"2004","unstructured":"Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644\u20139.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3640_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3640_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"key":"3640_CR12","unstructured":"Performance CLSI. Standards for Antimicrobial susceptibility testing. 33 ed. Clinical and Laboratory Standards Institute; 2023."},{"issue":"9","key":"3640_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1128\/jcm.25.9.1725-1729.1987","volume":"25","author":"RN Jones","year":"1987","unstructured":"Jones RN, Barry AL, Packer RR, Gregory WW, Thornsberry C. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination. J Clin Microbiol. 1987;25(9):1725\u20139.","journal-title":"J Clin Microbiol"},{"key":"3640_CR14","doi-asserted-by":"crossref","unstructured":"Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorl\u00ed L, Tubau F, G\u00f3mez-Zorrilla S et al. Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain. Antimicrob Agents Chemother 2017, 61(11).","DOI":"10.1128\/AAC.01589-17"},{"issue":"14","key":"3640_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","volume":"382","author":"JA Jernigan","year":"2020","unstructured":"Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC, McCarthy N, Paul P, McDonald LC, Kallen A, et al. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012\u20132017. N Engl J Med. 2020;382(14):1309\u201319.","journal-title":"N Engl J Med"},{"key":"3640_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","volume":"7","author":"G Raman","year":"2018","unstructured":"Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79.","journal-title":"Antimicrob Resist Infect Control"},{"key":"3640_CR17","doi-asserted-by":"publisher","first-page":"1137811","DOI":"10.3389\/fmicb.2023.1137811","volume":"14","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Guo L, Li B, Zhang S, Feng H, Zhang Y, Yu M, Hu H, Chen H, Yang Q, et al. Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study. Front Microbiol. 2023;14:1137811.","journal-title":"Front Microbiol"},{"issue":"4","key":"3640_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/cid\/ciaa065","volume":"72","author":"MJ Satlin","year":"2021","unstructured":"Satlin MJ. Languid uptake of ceftazidime-avibactam for carbapenem-resistant gram-negative infections and continued reliance on polymyxins. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2021;72(4):622\u20135.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"9","key":"3640_CR19","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/cid\/ciz530","volume":"70","author":"J Motsch","year":"2020","unstructured":"Motsch J, Murta de Oliveira C, Stus V, K\u00f6ksal I, Lyulko O, Boucher HW, Kaye KS, File TM, Brown ML, Khan I, et al. RESTORE-IMI 1: a multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem\/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;70(9):1799\u2013808.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"2","key":"3640_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","volume":"6","author":"P Pachori","year":"2019","unstructured":"Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis. 2019;6(2):109\u201319.","journal-title":"Genes Dis"},{"key":"3640_CR21","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2147\/IDR.S368566","volume":"15","author":"H Chen","year":"2022","unstructured":"Chen H, Mai H, Lopes B, Wen F, Patil S. Novel Pseudomonas aeruginosa strains co-harbouring bla (NDM-1) metallo \u03b2-Lactamase and mcr-1 isolated from immunocompromised paediatric patients. Infect drug Resist. 2022;15:2929\u201336.","journal-title":"Infect drug Resist"},{"key":"3640_CR22","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2147\/IDR.S180283","volume":"11","author":"T Liu","year":"2018","unstructured":"Liu T, Zhang Y, Wan Q. Pseudomonas aeruginosa bacteremia among liver transplant recipients. Infect drug Resist. 2018;11:2345\u201356.","journal-title":"Infect drug Resist"},{"key":"3640_CR23","doi-asserted-by":"publisher","first-page":"663020","DOI":"10.3389\/fmicb.2021.663020","volume":"12","author":"AM Rada","year":"2021","unstructured":"Rada AM, De La Cadena E, Agudelo CA, Pallares C, Restrepo E, Correa A, Villegas MV, Capataz C. Genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates carrying bla (VIM-2) and bla (KPC-2) genes that spread on different genetic environment in Colombia. Front Microbiol. 2021;12:663020.","journal-title":"Front Microbiol"},{"issue":"5","key":"3640_CR24","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1128\/AAC.04903-14","volume":"59","author":"YY Hu","year":"2015","unstructured":"Hu YY, Gu DX, Cai JC, Zhou HW, Zhang R. Emergence of KPC-2-producing Pseudomonas aeruginosa sequence type 463 isolates in Hangzhou, China. Antimicrob Agents Chemother. 2015;59(5):2914\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3640_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","volume":"45","author":"A Potron","year":"2015","unstructured":"Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45(6):568\u201385.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"3640_CR26","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/jac\/dkz176","volume":"74","author":"L Politi","year":"2019","unstructured":"Politi L, Gartzonika K, Spanakis N, Zarkotou O, Poulou A, Skoura L, Vrioni G, Tsakris A. Emergence of NDM-1-producing Klebsiella pneumoniae in Greece: evidence of a widespread clonal outbreak. J Antimicrob Chemother. 2019;74(8):2197\u2013202.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3640_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12941-021-00482-3","volume":"20","author":"M Shahin","year":"2021","unstructured":"Shahin M, Ahmadi A. Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran. Ann Clin Microbiol Antimicrob. 2021;20(1):76.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"3640_CR28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijantimicag.2018.05.017","volume":"52","author":"N Jaidane","year":"2018","unstructured":"Jaidane N, Naas T, Oueslati S, Bernabeu S, Boujaafar N, Bouallegue O, Bonnin RA. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. Int J Antimicrob Agents. 2018;52(6):916\u201321.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"3640_CR29","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1128\/AAC.00585-11","volume":"55","author":"L Poirel","year":"2011","unstructured":"Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother. 2011;55(11):5403\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3640_CR30","doi-asserted-by":"publisher","first-page":"e0426122","DOI":"10.1128\/spectrum.04261-22","volume":"11","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Chen D, Chen K, Xie M, Guo J, Chan EWC, Xie L, Wang J, Chen E, Chen S, et al. Epidemiological and genetic characteristics of clinical carbapenem-resistant Pseudomonas aeruginosa strains in Guangdong province, China. Microbiol Spectr. 2023;11(3):e0426122.","journal-title":"Microbiol Spectr"},{"key":"3640_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"21\u201322","author":"A Oliver","year":"2015","unstructured":"Oliver A, Mulet X, L\u00f3pez-Causap\u00e9 C, Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2015;21\u201322:41\u201359.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"5","key":"3640_CR32","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/femsre\/fux020","volume":"41","author":"S Chevalier","year":"2017","unstructured":"Chevalier S, Bouffartigues E, Bodilis J, Maillot O, Lesouhaitier O, Feuilloley MGJ, Orange N, Dufour A, Cornelis P. Structure, function and regulation of Pseudomonas aeruginosa porins. FEMS Microbiol Rev. 2017;41(5):698\u2013722.","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"3640_CR33","doi-asserted-by":"publisher","first-page":"e0005623","DOI":"10.1128\/mbio.00056-23","volume":"14","author":"CJ Hastings","year":"2023","unstructured":"Hastings CJ, Himmler GE, Patel A, Marques CNH. Immune response modulation by Pseudomonas aeruginosa persister cells. mBio. 2023;14(2):e0005623.","journal-title":"mBio"},{"issue":"1","key":"3640_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","volume":"19","author":"Z Chegini","year":"2020","unstructured":"Chegini Z, Khoshbayan A, Taati Moghadam M, Farahani I, Jazireian P, Shariati A. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob. 2020;19(1):45.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"3640_CR35","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2174\/1389557521666211202115259","volume":"22","author":"CH Ruiz","year":"2022","unstructured":"Ruiz CH, Osorio-Llanes E, Trespalacios MH, Mendoza-Torres E, Rosales W, G\u00f3mez CMM. Quorum sensing regulation as a target for antimicrobial therapy. Mini Rev Med Chem. 2022;22(6):848\u201364.","journal-title":"Mini Rev Med Chem"},{"key":"3640_CR36","doi-asserted-by":"crossref","unstructured":"Lorusso AB, Carrara JA, Barroso CDN, Tuon FF, Faoro H. Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa. Int J Mol Sci 2022, 23(24).","DOI":"10.3390\/ijms232415779"},{"key":"3640_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jgar.2023.08.020","volume":"35","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Xie L, Wang C, Zhou Q, Jelsbak L. Comparative whole-genome analysis of China and global epidemic Pseudomonas aeruginosa high-risk clones. J Global Antimicrob Resist. 2023;35:149\u201358.","journal-title":"J Global Antimicrob Resist"},{"key":"3640_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jgar.2024.04.002","volume":"38","author":"J Jiang","year":"2024","unstructured":"Jiang J, Liang L, Yuan Y. Genome analysis of extensively drug-resistant Pseudomonas aeruginosa ST1971 from a patient in China hospitalized for severe pneumonia. J Global Antimicrob Resist. 2024;38:123\u20137.","journal-title":"J Global Antimicrob Resist"},{"key":"3640_CR39","doi-asserted-by":"crossref","unstructured":"Sainz-Mej\u00edas M, Jurado-Mart\u00edn I, McClean S. Understanding Pseudomonas aeruginosa-host interactions: the ongoing quest for an efficacious vaccine. Cells 2020, 9(12).","DOI":"10.3390\/cells9122617"},{"issue":"6","key":"3640_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11274-021-03070-x","volume":"37","author":"IE Mba","year":"2021","unstructured":"Mba IE, Nweze EI. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects. World J Microbiol Biotechnol. 2021;37(6):108.","journal-title":"World J Microbiol Biotechnol"},{"issue":"7","key":"3640_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/14712598.2023.2226796","volume":"23","author":"P Espinal","year":"2023","unstructured":"Espinal P, Fust\u00e9 E, Sierra JM, Jim\u00e9nez-Galisteo G, Vinuesa T, Vi\u00f1as M. Progress towards the clinical use of antimicrobial peptides: challenges and opportunities. Expert Opin Biol Ther. 2023;23(7):641\u201350.","journal-title":"Expert Opin Biol Ther"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03640-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:04:35Z","timestamp":1731650675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3640"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03640-7","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patients and the study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval Number: 2024-E235-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"478"}}